⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
RDHL News
Redhill Biopharma Ltd.
RedHill's RHB-204 Demonstrates Comparable MAP Killing Efficacy to RHB-104 - Important Step in RHB-204 Development for MAP-related Crohn's Disease
prnewswire.com
RDHL
CPIX
RedHill Biopharma Announces Full-Year 2025 Financial Results and Operational Highlights
prnewswire.com
RDHL
CPIX
RedHill's Opaganib Enhances Efficacy of Neuroblastoma Chemo Combination and Augment Anti-Tumor Immunity in Triple-Negative Breast Cancer in Preclinical Studies - New Data Presented at AACR 2026
prnewswire.com
RDHL
CPIX
H. pylori Infections Market in the 6MM to Observe Stupendous Growth at a CAGR of 9.5% During the Forecast Period (2026-2036) | DelveInsight
prnewswire.com
RDHL
CPIX
PHAT
Biliary Tract Cancer Market is Predicted to Exhibit Remarkable Growth at a CAGR of 10.1% During the Forecast Period (2025-2034) | DelveInsight
prnewswire.com
CMPX
MRK
PFE
BOLD
REPL
RDHL
RLAY
LLY
INCY
JAZZ
Joint U.S. Commercialization of RedHill's Talicia® Commences
prnewswire.com
RDHL
CPIX
Ebola Virus Competitive Landscape Report 2026: Comprehensive Insights About 18+ Companies and 20+ Drugs
globenewswire.com
REGN
INO
RDHL
Rentschler Biopharma appoints Dr. Veit Bergendahl as Chief Operating Officer and member of the executive board
globenewswire.com
RDHL
RedHill's RHB-102 Progresses in Multiple GI Indications Including GLP-1 Therapy-Related GI Side Effects
prnewswire.com
RDHL
RedHill Biopharma's Positive Opaganib Results Indicate Reduction in Venetoclax Resistant Cells
prnewswire.com
RDHL
ABBV
GILD